OTC ¿Ü¿ë Ç×Áø±ÕÁ¦ ½ÃÀå : Á¦Ç° À¯Çüº°, À¯È¿ ¼ººÐº°, ¿ëµµº°, »ç¿ëÀÚº°, À¯Åë ä³Îº°, Áö¿ªº°
OTC Topical Antifungals Market, By Product Type, By Active Ingredient, By Application, By User, By Distribution Channel, By Geography
»óǰÄÚµå
:
1747309
¸®¼Ä¡»ç
:
Coherent Market Insights
¹ßÇàÀÏ
:
2025³â 05¿ù
ÆäÀÌÁö Á¤º¸
:
¿µ¹®
¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
»ùÇà ¿äû ¸ñ·Ï¿¡ Ãß°¡
OTC ¿Ü¿ë Ç×Áø±ÕÁ¦ ¼¼°è ½ÃÀåÀº 2025³â¿¡´Â 32¾ï 8,000¸¸ ´Þ·¯, 2032³â¿¡´Â 49¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, 2025-2032³â ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)Àº 5.9%¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
º¸°í¼ ¹üÀ§
º¸°í¼ »ó¼¼
±âÁØ ¿¬µµ
2024³â
2025³â ½ÃÀå ±Ô¸ð
32¾ï 8,000¸¸ ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ
2020-2024³â
¿¹Ãø ±â°£
2025-2032³â
¿¹Ãø ±â°£(2025-2032³â) CAGR
5.90%
2032³â °¡Ä¡ ¿¹Ãø
49¾ï ´Þ·¯
¼¼°è OTC ¿Ü¿ë Ç×Áø±ÕÁ¦ ½ÃÀåÀº °õÆÎÀÌ °¨¿°ÁõÀÇ À¯º´·ü Áõ°¡¿Í ÀϹÝÀǾàǰ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡·Î ÀÎÇØ ÃÖ±Ù ¸î ³â µ¿¾È °ý¸ñÇÒ ¸¸ÇÑ ¼ºÀå¼¼¸¦ º¸À̰í ÀÖ½À´Ï´Ù. ¿Ü¿ë Ç×Áø±ÕÁ¦´Â ¹«Á», ¹é¼±, ĵð´ÙÁõ µî ´Ù¾çÇÑ Áø±Õ °¨¿°À» Ä¡·áÇϱâ À§ÇØ ÇǺÎ, ¼ÕÅé, ¸ð¹ß¿¡ Á÷Á¢ ¹Ù¸£´Â ¾àÁ¦ÀÔ´Ï´Ù. ÀÌ ½ÃÀå¿¡´Â Å©¸², ¿¬°í, ½ºÇÁ·¹ÀÌ, ÆÄ¿ì´õ µî ´Ù¾çÇÑ Á¦Ç°ÀÌ ÀÖÀ¸¸ç, ó¹æÀü ¾øÀ̵µ ½±°Ô ±¸ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¦Ç°ÀÇ Æí¸®ÇÔ°ú Á¢±Ù¼ºÀº °õÆÎÀÌ °¨¿°À» ºü¸£°í È¿°úÀûÀ¸·Î Ä¡·áÇϰíÀÚ ÇÏ´Â ¼ÒºñÀÚµé »çÀÌ¿¡¼ Àα⸦ ²ø°í ÀÖ½À´Ï´Ù. °³ÀÎ À§»ý°ú Àڱ⠰ü¸®¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ¼¼°è OTC ¿Ü¿ë Ç×Áø±ÕÁ¦ ½ÃÀåÀº ´õ¿í È®´ëµÉ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ÀÌ´Â Á¦Á¶¾÷ü¿Í ¼Ò¸Å¾÷ü ¸ðµÎ¿¡°Ô À¯¸®ÇÑ ±âȸ¸¦ Á¦°øÇÒ °ÍÀÔ´Ï´Ù.
½ÃÀå ¿ªÇÐ
¼¼°è OTC ¿Ü¿ë Ç×Áø±ÕÁ¦ ½ÃÀåÀº ¼ºÀåÀ» °¡¼ÓÇÏ°í °úÁ¦¿Í ±âȸ¸¦ Á¦°øÇÏ´Â ¸î °¡Áö Áß¿äÇÑ ¿äÀÎÀÇ ¿µÇâÀ» ¹Þ°í ÀÖ½À´Ï´Ù. ÁÖ¿ä ÃËÁø¿äÀÎ Áß Çϳª´Â ƯÈ÷ ¿´ë ±âÈÄ¿Í ¿¾ÇÇÑ À§»ý ȯ°æÀ» °¡Áø ½ÅÈï ±¹°¡¿¡¼ °õÆÎÀÌ °¨¿° Áõ°¡ÀÔ´Ï´Ù. ¶ÇÇÑ, °õÆÎÀÌ °¨¿°¿¡ Ãë¾àÇÑ ´ç´¢º´ÀÇ À¯º´·üÀÌ Áõ°¡Çϰí ÀÖ´Â °Íµµ ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, °³ÀÎ À§»ý°ú °õÆÎÀÌ °¨¿°¿¡ ´ëÇÑ ½Å¼ÓÇÑ Ä¡·áÀÇ Á߿伺¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö¸é¼ OTC ¿Ü¿ë Ç×Áø±ÕÁ¦¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ±×·¯³ª ó¹æ¾à ¹× °¡Á¤ ¿ä¹ý°ú °°Àº ´ëü Ä¡·á ¿É¼ÇÀ» »ç¿ëÇÒ ¼ö ÀÖ´Â µî ½ÃÀå¿¡´Â ƯÁ¤ ¾ïÁ¦¿äÀÎÀÌ ÀÖÀ¸¸ç, ÀÌ´Â ½ÃÀåÀÇ ¼ºÀ强À» Á¦ÇÑÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀϺΠ¿Ü¿ë Ç×Áø±ÕÁ¦´Â ÇǺΠÀÚ±ØÀ̳ª ¾Ë·¹¸£±â ¹ÝÀÀ°ú °°Àº ºÎÀÛ¿ëÀ» À¯¹ßÇÒ ¼ö ÀÖ¾î ÀϺΠ¼ÒºñÀÚµéÀÌ »ç¿ëÀ» ²¨¸®´Â °æ¿ìµµ ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¹®Á¦¿¡µµ ºÒ±¸Çϰí, ÀÌ ½ÃÀåÀº ƯÁ¤ ¼ÒºñÀÚÀÇ ´ÏÁî¿Í ÃëÇâ¿¡ ¸Â´Â Çõ½ÅÀûÀ̰í Ÿ°ÙÆÃµÈ Á¦Á¦¸¦ °³¹ßÇÏ´Â Á¦Á¶¾÷ü¿¡°Ô´Â Å« ºñÁî´Ï½º ±âȸ°¡ µÉ ¼ö ÀÖ½À´Ï´Ù. õ¿¬ ¹× À¯±â³ó Ç×Áø±Õ Á¦Ç°¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿Í ½ÅÈï ½ÃÀåÀ¸·ÎÀÇ È®Àå °¡´É¼ºÀº ¼¼°è OTC ¿Ü¿ë Ç×Áø±ÕÁ¦ ½ÃÀå¿¡ À¯¸ÁÇÑ ¼ºÀå °æ·Î¸¦ Á¦°øÇÕ´Ï´Ù.
º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡
¼¼°èÀÇ OTC ¿Ü¿ë Ç×Áø±ÕÁ¦ ½ÃÀåÀ» »ó¼¼ÇÏ°Ô ºÐ¼®ÇÏ¿© 2024³âÀ» ±âÁØ ¿¬µµ, 2025-2032³â±îÁöÀÇ ¿¹Ãø ±â°£(2025-2032³â) ½ÃÀå ±Ô¸ð(¹ÌÈ¾ï ´Þ·¯)¿Í ¿¬Æò±Õ ¼ºÀå·ü(CAGR)À» Á¶»çÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
¶ÇÇÑ, ´Ù¾çÇÑ ºÎ¹®¿¡ °ÉÄ£ ÀáÀçÀû ¼öÀÍ ±âȸ¸¦ ¹àÈ÷°í, ÀÌ ½ÃÀåÀÇ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾È ¸ÅÆ®¸¯½º¸¦ ¼³¸íÇÕ´Ï´Ù.
¶ÇÇÑ ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ, ½ÅÁ¦Ç° Ãâ½Ã ¹× ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ªº° Àü¸Á, ÁÖ¿ä ±â¾÷ÀÇ °æÀï Àü·« µî¿¡ ´ëÇÑ ÁÖ¿ä °íÂûÀ» Á¦°øÇÕ´Ï´Ù.
ÀÌ º¸°í¼´Â ±â¾÷ ÇÏÀ̶óÀÌÆ®, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÁÖ¿ä ÇÏÀ̶óÀÌÆ®, À繫 ¼º°ú, Àü·« µîÀÇ ¸Å°³ º¯¼ö¸¦ ±â¹ÝÀ¸·Î ¼¼°è OTC ¿Ü¿ë Ç×Áø±ÕÁ¦ ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷ ÇÁ·ÎÆÄÀÏÀ» Á¦°øÇÕ´Ï´Ù.
ÀÌ º¸°í¼ÀÇ ÅëÂû·ÂÀ» ÅëÇØ ¸¶ÄÉÆÃ ´ã´çÀÚ¿Í ±â¾÷ °æ¿µÁøÀº ÇâÈÄ Á¦Ç° Ãâ½Ã, À¯ÇüÈ, ½ÃÀå È®´ë, ¸¶ÄÉÆÃ Àü·«¿¡ ´ëÇÑ Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖÀ» °ÍÀÔ´Ï´Ù.
OTC ¿Ü¿ë Ç×Áø±ÕÁ¦ ¼¼°è ½ÃÀå º¸°í¼´Â ÅõÀÚÀÚ, °ø±Þ¾÷ü, Á¦Ç° Á¦Á¶¾÷ü, À¯Åë¾÷ü, ½Å±Ô Âü°¡ÀÚ, À繫 ºÐ¼®°¡ µî ¾÷°èÀÇ ´Ù¾çÇÑ ÀÌÇØ°ü°èÀÚ¸¦ ´ë»óÀ¸·Î ÇÕ´Ï´Ù.
ÀÌÇØ°ü°èÀÚµéÀº ¼¼°è OTC ¿Ü¿ë Ç×Áø±ÕÁ¦ ½ÃÀåÀ» ºÐ¼®ÇÒ ¶§ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÇ»ç°áÁ¤À» ¿ëÀÌÇÏ°Ô ÇÒ ¼ö ÀÖ½À´Ï´Ù.
¸ñÂ÷
Á¦1Àå Á¶»ç ¸ñÀû°ú ÀüÁ¦Á¶°Ç
Á¦2Àå ½ÃÀå Àü¸Á
Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®
½ÃÀå ¿ªÇÐ
¼ºÀå ÃËÁø¿äÀÎ
¼ºÀå ¾ïÁ¦¿äÀÎ
±âȸ
¿µÇ⠺м®
ÁÖ¿ä ¹ßÀü
±ÔÁ¦ ½Ã³ª¸®¿À
Á¦Ç° ¹ß¸Å ¹× ½ÂÀÎ
PEST ºÐ¼®
PORTER ºÐ¼®
ÀμöÇÕº´(M&A) ½Ã³ª¸®¿À
¾÷°è µ¿Çâ
Á¦4Àå ¼¼°èÀÇ OTC ¿Ü¿ë Ç×Áø±ÕÁ¦ ½ÃÀå, Á¦Ç° À¯Çüº°, 2020³â-2032³â
Å©¸²
¿¬°í
½ºÇÁ·¹ÀÌ
ºÐ¸»
°Ö
·Î¼Ç
Á¦5Àå ¼¼°èÀÇ OTC ¿Ü¿ë Ç×Áø±ÕÁ¦ ½ÃÀå, À¯È¿ ¼ººÐº°, 2020³â-2032³â
Clotrimazole
Miconazole
Terbinafine
Ketoconazole
Tolnaftate
±âŸ
Á¦6Àå ¼¼°èÀÇ OTC ¿Ü¿ë Ç×Áø±ÕÁ¦ ½ÃÀå, ¿ëµµº°, 2020³â-2032³â
ÇǺλç»ó±Õ °¨¿°
È¿¸ð °¨¿°
¼Õ¹ßÅé °¨¿°
¹é¼± ºÎÁ»
¹«Á»
Á¦7Àå ¼¼°èÀÇ OTC ¿Ü¿ë Ç×Áø±ÕÁ¦ ½ÃÀå, »ç¿ëÀÚº°, 2020³â-2032³â
Á¦8Àå ¼¼°èÀÇ OTC ¿Ü¿ë Ç×Áø±ÕÁ¦ ½ÃÀå, À¯Åë ä³Îº°, 2020³â-2032³â
¿Â¶óÀÎ ¾à±¹
¼Ò¸Å ¾à±¹
½´ÆÛ¸¶ÄÏ ¹× ÇÏÀÌÆÛ¸¶ÄÏ
Àü¹®Á¡
Á¦9Àå ¼¼°èÀÇ OTC ¿Ü¿ë Ç×Áø±ÕÁ¦ ½ÃÀå, Áö¿ªº°, 2020³â-2032³â
ºÏ¹Ì
¶óƾ¾Æ¸Þ¸®Ä«
ºê¶óÁú
¾Æ¸£ÇîÆ¼³ª
¸ß½ÃÄÚ
±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
À¯·´
µ¶ÀÏ
¿µ±¹
½ºÆäÀÎ
ÇÁ¶û½º
ÀÌÅ»¸®¾Æ
·¯½Ã¾Æ
±âŸ À¯·´
¾Æ½Ã¾ÆÅÂÆò¾ç
Áß±¹
Àεµ
ÀϺ»
È£ÁÖ
Çѱ¹
ASEAN
±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
秵GCC ±¹°¡
À̽º¶ó¿¤
±âŸ Áßµ¿
¾ÆÇÁ¸®Ä«
³²¾ÆÇÁ¸®Ä«
ºÏ¾ÆÇÁ¸®Ä«
Áß¾Ó¾ÆÇÁ¸®Ä«
Á¦10Àå °æÀï ±¸µµ
Johnson & Johnson
Bayer AG
GlaxoSmithKline
Pfizer Inc.
Novartis AG
Merck & Co., Inc.
Abbott Laboratories
Sanofi S.A.
Astellas Pharma Inc.
Mylan N.V.
Amgen Inc.
Teva Pharmaceutical Industries Ltd.
Valeant Pharmaceuticals International
Reddy's Laboratories
Sun Pharmaceutical Industries Ltd.
Á¦11Àå ¾Ö³Î¸®½ºÆ® Ãßõ »çÇ×
±âȸ
¾Ö³Î¸®½ºÆ®ÀÇ °ßÇØ
Coherent Opportunity Map
Á¦12Àå Âü°í ¹®Çå°ú Á¶»ç ¹æ¹ý
Âü°í ¹®Çå
Á¶»ç ¹æ¹ý
ÃâÆÇ»ç¿¡ ´ëÇØ
LSH
¿µ¹® ¸ñÂ÷
Global OTC Topical Antifungals Market is estimated to be valued at USD 3.28 Bn in 2025 and is expected to reach USD 4.90 Bn by 2032, growing at a compound annual growth rate (CAGR) of 5.9% from 2025 to 2032.
Report Coverage
Report Details
Base Year:
2024
Market Size in 2025:
USD 3.28 Bn
Historical Data for:
2020 To 2024
Forecast Period:
2025 To 2032
Forecast Period 2025 to 2032 CAGR:
5.90%
2032 Value Projection:
USD 4.90 Bn
The global OTC topical antifungals market has witnessed significant growth in recent years, driven by the increasing prevalence of fungal infections and the rising demand for over-the-counter remedies. Topical antifungals are medications applied directly to the skin, nails, or hair to treat various fungal infections, such as athlete's foot, ringworm, and candidiasis. The market encompasses a wide range of products, including creams, ointments, sprays, and powders, which are readily available without a prescription. The convenience and accessibility of these products have contributed to their popularity among consumers seeking quick and effective relief from fungal infections. As awareness about personal hygiene and self-care continues to grow, the global OTC topical antifungals market is expected to expand further, offering lucrative opportunities for manufacturers and retailers alike.
Market Dynamics
The global OTC topical antifungals market is influenced by several key factors that drive its growth, pose challenges, and present opportunities. One of the primary drivers is the increasing prevalence of fungal infections worldwide, particularly in developing countries with tropical climates and poor hygiene conditions. The rising incidence of diabetes, which makes individuals more susceptible to fungal infections, also contributes to the market's growth. Additionally, the growing awareness about personal hygiene and the importance of prompt treatment for fungal infections has led to a higher demand for OTC topical antifungals. However, the market faces certain restraints, such as the availability of alternative treatment options, including prescription medications and home remedies, which may limit its growth potential. Moreover, the side effects associated with some topical antifungals, such as skin irritation and allergic reactions, may deter some consumers from using these products. Despite these challenges, the market presents significant opportunities for manufacturers to develop innovative and targeted formulations that address specific consumer needs and preferences. The increasing demand for natural and organic antifungal products, as well as the potential for expansion into emerging markets, offers promising avenues for growth in the global OTC topical antifungals market.
Key Features of the Study
This report provides in-depth analysis of the global OTC topical antifungals market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global OTC topical antifungals market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Johnson & Johnson, Bayer AG, GlaxoSmithKline, Pfizer Inc., Novartis AG, Merck & Co., Inc., Abbott Laboratories, Sanofi S.A., Astellas Pharma Inc., Mylan N.V., Amgen Inc., Teva Pharmaceutical Industries Ltd., Valeant Pharmaceuticals International, Dr. Reddy's Laboratories, and Sun Pharmaceutical Industries Ltd.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global OTC topical antifungals market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global OTC topical antifungals market
Market Segmentation
Product Type Insights (Revenue, USD Bn, 2020 - 2032)
Creams
Ointments
Sprays
Powders
Gels
Lotions
Active Ingredient Insights (Revenue, USD Bn, 2020 - 2032)
Clotrimazole
Miconazole
Terbinafine
Ketoconazole
Tolnaftate
Others
Application Insights (Revenue, USD Bn, 2020 - 2032)
Dermatophyte Infections
Yeast Infections
Nail Infections
Ringworm
Athlete's Foot
User Insights (Revenue, USD Bn, 2020 - 2032)
Adults
Pediatrics
Geriatrics
Distribution Channel Insights (Revenue, USD Bn, 2020 - 2032)
Online Pharmacies
Retail Pharmacies
Supermarkets/Hypermarkets
Specialty Stores
Regional Insights (Revenue, USD Bn, 2020 - 2032)
North America
U.S.
Canada
Latin America
Brazil
Argentina
Mexico
Rest of Latin America
Europe
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
GCC Countries
Israel
Rest of Middle East
Africa
South Africa
North Africa
Central Africa
Key Players Insights
Johnson & Johnson
Bayer AG
GlaxoSmithKline
Pfizer Inc.
Novartis AG
Merck & Co., Inc.
Abbott Laboratories
Sanofi S.A.
Astellas Pharma Inc.
Mylan N.V.
Amgen Inc.
Teva Pharmaceutical Industries Ltd.
Valeant Pharmaceuticals International
Reddy's Laboratories
Sun Pharmaceutical Industries Ltd.
Table of Contents
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Global OTC Topical Antifungals Market, By Product Type
Global OTC Topical Antifungals Market, By Active Ingredient
Global OTC Topical Antifungals Market, By Application
Global OTC Topical Antifungals Market, By User
Global OTC Topical Antifungals Market, By Distribution Channel
Global OTC Topical Antifungals Market, By Region
3. Market Dynamics, Regulations,and Trends Analysis
Market Dynamics
Driver
Restraint
Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends
4. Global OTC Topical Antifungals Market, By Product Type, 2020-2032, (USD Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Creams
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Ointments
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Sprays
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Powders
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Gels
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Lotions
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
5. Global OTC Topical Antifungals Market, By Active Ingredient, 2020-2032, (USD Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Clotrimazole
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Miconazole
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Terbinafine
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Ketoconazole
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Tolnaftate
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
6. Global OTC Topical Antifungals Market, By Application, 2020-2032, (USD Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Dermatophyte Infections
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Yeast Infections
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Nail Infections
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Ringworm
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Athlete's Foot
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
7. Global OTC Topical Antifungals Market, By User, 2020-2032, (USD Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Adults
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Pediatrics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Geriatrics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
8. Global OTC Topical Antifungals Market, By Distribution Channel, 2020-2032, (USD Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Supermarkets/Hypermarkets
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Specialty Stores
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
9. Global OTC Topical Antifungals Market, By Region, 2020 - 2032, Value (USD Bn)
Introduction
Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
Regional Trends
North America
Introduction
Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Active Ingredient, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By User, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
Latin America
Introduction
Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Active Ingredient, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By User, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
Brazil
Argentina
Mexico
Rest of Latin America
Europe
Introduction
Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Active Ingredient, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By User, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Active Ingredient, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By User, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
Introduction
Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Active Ingredient, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By User, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
GCC Countries
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Active Ingredient, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By User, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
South Africa
North Africa
Central Africa
10. Competitive Landscape
Johnson & Johnson
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Bayer AG
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
GlaxoSmithKline
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Pfizer Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Novartis AG
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Merck & Co., Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Abbott Laboratories
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Sanofi S.A.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Astellas Pharma Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Mylan N.V.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Amgen Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Teva Pharmaceutical Industries Ltd.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Valeant Pharmaceuticals International
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Reddy's Laboratories
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Sun Pharmaceutical Industries Ltd.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
11. Analyst Recommendations
Wheel of Fortune
Analyst View
Coherent Opportunity Map
12. References and Research Methodology
References
Research Methodology
About us
°ü·ÃÀÚ·á